Shashidhar H. Kori
Amministratore Delegato presso Novilla Pharmaceuticals Inc
Profilo
Shashidhar H.
Kori is currently the Chief Executive Officer at Novilla Pharmaceuticals Inc. Prior to this, he held senior positions at GSK Plc, MAP Pharmaceuticals LLC, Trigemina, Inc., Autonomic Technologies, Inc., and Allergan Pharmaceuticals Ltd., Inc. He holds a doctorate degree from the University of Mysore and Kasturba Medical College, and an undergraduate degree from St. Joseph's College.
Posizioni attive di Shashidhar H. Kori
| Società | Posizione | Inizio |
|---|---|---|
Novilla Pharmaceuticals Inc
 Novilla Pharmaceuticals Inc Pharmaceuticals: MajorHealth Technology Novilla Pharmaceuticals Inc is an American biotechnology company that specializes in delivering medications. The CEO of the company is Shashidhar H. Kori. | Amministratore Delegato | - |
Precedenti posizioni note di Shashidhar H. Kori
| Società | Posizione | Fine |
|---|---|---|
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Direttore Tecnico/Scientifico/R&S | - |
Allergan Pharmaceuticals Ltd., Inc.
 Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Direttore Tecnico/Scientifico/R&S | - |
| GSK PLC | Direttore Tecnico/Scientifico/R&S | - |
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Direttore Tecnico/Scientifico/R&S | - |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Shashidhar H. Kori
| University of Mysore | Doctorate Degree |
| St. Joseph's College | Undergraduate Degree |
| Kasturba Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 5 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
Allergan Pharmaceuticals Ltd., Inc.
Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Health Technology |
Novilla Pharmaceuticals Inc
Novilla Pharmaceuticals Inc Pharmaceuticals: MajorHealth Technology Novilla Pharmaceuticals Inc is an American biotechnology company that specializes in delivering medications. The CEO of the company is Shashidhar H. Kori. | Health Technology |
- Borsa valori
- Insiders
- Shashidhar H. Kori
